Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias [Phase 2]
Phase 2 study of bosutinib (SKI-606) in Philadelphia chromosome-positive leukemias, including chronic myeloid leukemia, completed with resul…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis [Phase 2]
This update reports the completion of a Phase 2 trial evaluating imatinib (STI571) in patients with chronic myeloid leukemia in blast crisis…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 trial evaluating homoharringtonine in combination with interferon alfa for chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate [Phase 1]
Phase 1 clinical trial update of dasatinib in pediatric patients with Philadelphia chromosome–positive leukemia or recurrent/refractory soli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission [Phase 1]
Phase 1 trial evaluating the use of G-CSF to stimulate peripheral blood stem cell collection for autologous stem cell transplantation in pat…
-
FDA approval · 2013-01-25FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for GLEEVEC (imatinib mesylate) submitted by Novartis, reflecting changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of STI571 (imatinib) with cytarabine in patients with chronic myeloid leukemia, includ…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating the combination of triapine (3-AP) with high-dose cytarabine in adults with advanced hematologic malignancies has c…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated the combination of imatinib mesylate and decitabine for chronic myeloid leukemia, including accelerated- …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update on Homoharringtonine for chronic myeloid leukemia, including chronic-phase and pediatric cases, with study sta…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study of bevacizumab, idarubicin, and cytarabine in patients with blast phase chronic myeloid leukemia (including BCR-ABL1-positiv…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa [Phase 2]
Phase 2 trial of STI571 (imatinib) in patients with chronic myeloid leukemia that has not responded to interferon alfa has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial update of imatinib mesylate for chronic myeloid leukemia has completed. The study included pediatric and BCR-ABL1–p…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [Phase 1]
Phase 1 trial evaluating FR901228 in pediatric patients with refractory or recurrent solid tumors or leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and imatinib mesylate in patients with chronic myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]
This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia
This clinical trial update reports completion of a study evaluating intracellular and plasma levels of imatinib in patients with chronic mye…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating sorafenib in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chronic …
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Phase 1]
Phase 1 study assessing the safety of adding sargramostim (GM-CSF) to chemotherapy in patients with refractory myeloid cancers; the trial ha…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating dasatinib in patients with chronic myeloid leukemia or acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Treatment Modification Based on Early Assessment of CML Patients [Phase 2]
A Phase 2 clinical trial update discussing treatment modification for chronic myeloid leukemia patients based on early assessment.